EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 60 filers reported holding EPIZYME INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $68,000 | -86.1% | 46,532 | -89.0% | 0.00% | – |
| Q1 2022 | $489,000 | -38.9% | 424,776 | +32.7% | 0.00% | – |
| Q4 2021 | $800,000 | -48.6% | 320,177 | +5.4% | 0.00% | – |
| Q3 2021 | $1,555,000 | -32.2% | 303,763 | +10.2% | 0.00% | – |
| Q2 2021 | $2,292,000 | -23.8% | 275,757 | -20.2% | 0.00% | -100.0% |
| Q1 2021 | $3,009,000 | -21.0% | 345,412 | -1.6% | 0.00% | 0.0% |
| Q4 2020 | $3,811,000 | -8.8% | 350,947 | +0.1% | 0.00% | 0.0% |
| Q3 2020 | $4,181,000 | -27.1% | 350,511 | -1.8% | 0.00% | -50.0% |
| Q2 2020 | $5,732,000 | +4.5% | 356,975 | +0.9% | 0.00% | 0.0% |
| Q1 2020 | $5,486,000 | -39.6% | 353,681 | -4.2% | 0.00% | 0.0% |
| Q4 2019 | $9,081,000 | +172.9% | 369,152 | +14.5% | 0.00% | +100.0% |
| Q3 2019 | $3,327,000 | -16.3% | 322,519 | +1.8% | 0.00% | 0.0% |
| Q2 2019 | $3,976,000 | +18.1% | 316,862 | +16.6% | 0.00% | 0.0% |
| Q1 2019 | $3,367,000 | +111.5% | 271,752 | +5.2% | 0.00% | – |
| Q4 2018 | $1,592,000 | -33.4% | 258,442 | +14.6% | 0.00% | -100.0% |
| Q3 2018 | $2,389,000 | -21.9% | 225,422 | -0.2% | 0.00% | 0.0% |
| Q2 2018 | $3,058,000 | -21.6% | 225,764 | +2.7% | 0.00% | 0.0% |
| Q1 2018 | $3,901,000 | +46.0% | 219,752 | +3.2% | 0.00% | 0.0% |
| Q4 2017 | $2,672,000 | -30.6% | 212,983 | +5.3% | 0.00% | 0.0% |
| Q3 2017 | $3,852,000 | +29.5% | 202,178 | +2.6% | 0.00% | 0.0% |
| Q2 2017 | $2,975,000 | -11.9% | 197,038 | +0.1% | 0.00% | 0.0% |
| Q1 2017 | $3,377,000 | +53.4% | 196,837 | +8.2% | 0.00% | 0.0% |
| Q4 2016 | $2,201,000 | +34.9% | 181,859 | +9.7% | 0.00% | – |
| Q3 2016 | $1,631,000 | -6.0% | 165,819 | -2.1% | 0.00% | -100.0% |
| Q2 2016 | $1,735,000 | -14.0% | 169,352 | +1.7% | 0.00% | 0.0% |
| Q1 2016 | $2,018,000 | +6.3% | 166,486 | +40.5% | 0.00% | 0.0% |
| Q4 2015 | $1,899,000 | +20.1% | 118,535 | -3.6% | 0.00% | – |
| Q3 2015 | $1,581,000 | -52.2% | 122,913 | -10.8% | 0.00% | -100.0% |
| Q2 2015 | $3,307,000 | +127.6% | 137,755 | +78.0% | 0.00% | – |
| Q1 2015 | $1,453,000 | +35.9% | 77,400 | +36.6% | 0.00% | – |
| Q4 2014 | $1,069,000 | -34.5% | 56,666 | -5.9% | 0.00% | – |
| Q3 2014 | $1,632,000 | -48.7% | 60,227 | -41.1% | 0.00% | – |
| Q2 2014 | $3,182,000 | +422.5% | 102,210 | +282.1% | 0.00% | – |
| Q1 2014 | $609,000 | +11.7% | 26,750 | +2.0% | 0.00% | – |
| Q4 2013 | $545,000 | -71.1% | 26,225 | -44.3% | 0.00% | – |
| Q3 2013 | $1,884,000 | +184.6% | 47,122 | +100.3% | 0.00% | – |
| Q2 2013 | $662,000 | – | 23,531 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $79,842,000 | 29.97% |
| Foresite Capital Management III, LLC | 998,278 | $8,695,000 | 7.64% |
| KPCB XIII Associates, LLC | 3,838,166 | $33,430,000 | 6.87% |
| Burrage Capital Management LLC | 564,555 | $4,917,000 | 3.98% |
| Palo Alto Investors LP | 6,856,513 | $59,720,000 | 3.40% |
| MPM BioImpact LLC | 2,331,534 | $20,308,000 | 2.55% |
| Foresite Capital Management II, LLC | 1,000,002 | $8,710,000 | 2.00% |
| Foresite Capital Management I, LLC | 293,759 | $2,559,000 | 1.29% |
| Redmile Group, LLC | 8,824,366 | $76,860,000 | 1.08% |
| Rock Springs Capital Management LP | 2,802,954 | $24,414,000 | 0.53% |